Activation of 5-HT2CR suppresses the induction and expression of behavioral sensitization induced by morphine.
Activation of 5-HT2CR ameliorates naloxone-precipitated withdrawal symptoms in morphine-dependent mice.
Chronic morphine exposure increases 5-HT2CR expression in ventral tegmental area, locus coeruleus and nucleus accumbens.
5-HT2CR may be a drug target for preventing the abuse and dependence of opioid.